| ［1］ |
陈玲玲, 路丹丹, 施辛, 等. 肿瘤坏死因子α拮抗剂治疗一例伴嗜酸性粒细胞增多和系统症状药疹的临床观察［J］. 中华皮肤科杂志, 2013,46（9）:621⁃625.
|
| ［2］ |
中国医师协会皮肤科医师分会变态反应性疾病专业委员会. 药物超敏反应综合征诊治专家共识［J］. 中华皮肤科杂志, 2018,51（11）:787⁃790. doi: 10.3760/cma.j.issn.0412⁃4030.2018. 11.002.
|
| ［3］ |
Al⁃Salama ZT. Apalutamide: first global approval［J］. Drugs, 2018,78（6）:699⁃705. doi: 10.1007/s40265⁃018⁃0900⁃z.
|
| ［4］ |
Perez⁃Ruixo C, Ackaert O, Ouellet D, et al. Efficacy and safety exposure⁃response relationships of apalutamide in patients with nonmetastatic castration⁃resistant prostate cancer［J］. Clin Cancer Res, 2020,26（17）:4460⁃4467. doi: 10.1158/1078⁃0432.CCR⁃20⁃1041.
|
| ［5］ |
Kardaun SH, Sidoroff A, Valeyrie⁃Allanore L, et al. Variability in the clinical pattern of cutaneous side⁃effects of drugs with systemic symptoms: does a DRESS syndrome really exist?［J］. Br J Dermatol, 2007,156（3）:609⁃611. doi: 10.1111/j.1365⁃2133. 2006.07704.x.
|
| ［6］ |
Shiohara T, Iijima M, Ikezawa Z, et al. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations［J］. Br J Dermatol, 2007,156（5）:1083⁃1084. doi: 10.1111/j.1365⁃2133.2007.07807.x.
|
| ［7］ |
Ducharme O, Sanchez⁃Pena P, Pham⁃Ledard A, et al. The first case of drug reaction with eosinophilia and systemic symptoms （DRESS） syndrome caused by apalutamide, a novel oral androgen receptor antagonist［J］. Contact Dermatitis, 2022,86（4）:313⁃315. doi: 10.1111/cod.14024.
|
| ［8］ |
Endo Y, Oka A, Uehara A, et al. Fatal case of toxic epidermal necrolysis due to apalutamide used as a novel prostate cancer drug［J］. J Dermatol, 2020,47（10）:e359⁃e360. doi: 10.1111/1346⁃8138.15510.
|
| ［9］ |
Miyagawa A, Adachi T, Kobayashi Y, et al. Plasmapheresis as a promising treatment option in apalutamide⁃associated toxic epidermal necrolysis［J］. J Dermatol, 2022,49（3）:e102⁃e103. doi: 10.1111/1346⁃8138.16248.
|
| ［10］ |
Osawa K, Kiniwa Y, Shimosato Y, et al. Toxic epidermal necrolysis caused by apalutamide: a case report of treatment using etanercept with conventional steroid therapy［J］. Acta Derm Venereol, 2022,102:adv00723. doi: 10.2340/actadv.v102.2243.
|
| ［11］ |
Honda T, Tohi Y, Kaku Y, et al. Acute generalized exanthematous pustulosis during apalutamide treatment in a patient with prostate cancer［J］. IJU Case Rep, 2022,5（6）:497⁃500. doi: 10. 1002/iju5.12525.
|
| ［12］ |
经晶, 路丹丹, 施辛, 等. 肿瘤坏死因子α拮抗剂治疗Stevens⁃Johnson综合征17例［J］. 中华皮肤科杂志, 2016,49（7）:465⁃468.doi: 10.3760/cma.j.issn.0412⁃4030.2016.07.004.
|
